News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin
Mydecine Innovations Group
Mind Cure Welcomes Award-Winning Journalist and Science Researcher Hamilton Morris to Advisory Board
MINDCURE
Field Trip Health Ltd. to Commence Trading on the CSE on October 6 Under Ticker Symbol FTRP
Field Trip Health
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines
Mind Medicine (MindMed)
Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.
Braxia Scientific Corp.
Celia Morgan, Professor of Psychopharmacology at University of Exeter and Leading Ketamine Investigator, Joins AWAKN Life Sciences
Awakn Life Sciences
Field Trip Health Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange
Field Trip Health
Sansero Life Sciences Announces Joint Study With the University of Toronto to Advance Clinical Research of Psychedelic Medications
GoodCap Wellness
Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today
Mydecine Innovations Group
Optimi Health Corp. Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of $4.5 Million
Optimi Health
Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Revive Therapeutics
Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development
Field Trip Health
Better Plant Sciences Subsidiary NeonMind Signs Psilocybin Supply Agreement for Clinical Trials
NeonMind Biosciences Inc.
Psygen Labs
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.